Osaic Holdings’s Annovis Bio ANVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22 Sell
10
-200
-95% -$548 ﹤0.01% 7714
2025
Q4
$727 Hold
210
﹤0.01% 7357
2025
Q3
$429 Sell
210
-467
-69% -$1.17K ﹤0.01% 7566
2025
Q2
$1.47K Buy
677
+75
+12% +$148 ﹤0.01% 7044
2025
Q1
$903 Buy
602
+100
+20% +$306 ﹤0.01% 6858
2024
Q4
$2.52K Sell
502
-698
-58% -$5.05K ﹤0.01% 6511
2024
Q3
$9.67K Sell
1,200
-75
-6% -$703 ﹤0.01% 5836
2024
Q2
$7.34K Buy
1,275
+75
+6% +$608 ﹤0.01% 5972
2024
Q1
$14.3K Hold
1,200
﹤0.01% 5547
2023
Q4
$22.4K Hold
1,200
﹤0.01% 5438
2023
Q3
$11.4K Sell
1,200
-956
-44% -$11.8K ﹤0.01% 5852
2023
Q2
$30.1K Hold
2,156
﹤0.01% 5286
2023
Q1
$30.5K Sell
2,156
-1,210
-36% -$19.5K ﹤0.01% 5308
2022
Q4
$45K Buy
3,366
+86
+3% +$1.07K ﹤0.01% 5012
2022
Q3
$45K Buy
3,280
+1,210
+58% +$15.9K ﹤0.01% 4988
2022
Q2
$25K Sell
2,070
-800
-28% -$8.75K ﹤0.01% 5453
2022
Q1
$38K Sell
2,870
-5,724
-67% -$82.7K ﹤0.01% 5278
2021
Q4
$152K Sell
8,594
-2,408
-22% -$62.1K ﹤0.01% 4213
2021
Q3
$349K Buy
11,002
+9,260
+532% +$532K ﹤0.01% 3393
2021
Q2
$149K Sell
1,742
-2,458
-59% -$114K ﹤0.01% 4130
2021
Q1
$117K Sell
4,200
-3,196
-43% -$68.4K ﹤0.01% 4215
2020
Q4
$56K Sell
7,396
-438
-6% -$2.37K ﹤0.01% 4475
2020
Q3
$38K Buy
7,834
+7,409
+1,743% +$39.7K ﹤0.01% 4499
2020
Q2
$2K Hold
425
﹤0.01% 5757
2020
Q1
$1K Buy
+425
New +$2.09K ﹤0.01% 5792

Other funds holding ANVS

Osaic Holdings's ANVS Position: Q1 2026 in Review

Osaic Holdings reduced its Annovis Bio (ANVS) stake by 95% in Q1 2026, selling an estimated $548 and leaving 10 shares worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #7714.

Osaic Holdings first reported a position in ANVS in Q1 2020 and has held it in 25 quarters since. The position peaked at $349K in Q3 2021. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

  • Osaic Holdings held 10 shares of Annovis Bio worth $22 as of Q1 2026.
  • Osaic Holdings sold 200 Annovis Bio shares in Q1 2026, an estimated $548.
  • Annovis Bio made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7714 holding.
  • Osaic Holdings first reported a position in Annovis Bio in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Annovis Bio position peaked at $349K in Q3 2021.
  • 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.